nodes	percent_of_prediction	percent_of_DWPC	metapath
Vigabatrin—Dermatitis—Mechlorethamine—lymphatic system cancer	0.00279	0.00279	CcSEcCtD
Vigabatrin—Speech disorder—Methotrexate—lymphatic system cancer	0.00277	0.00277	CcSEcCtD
Vigabatrin—Erectile dysfunction—Mitoxantrone—lymphatic system cancer	0.00277	0.00277	CcSEcCtD
Vigabatrin—Pneumonia—Vincristine—lymphatic system cancer	0.00277	0.00277	CcSEcCtD
Vigabatrin—Depression—Vincristine—lymphatic system cancer	0.00274	0.00274	CcSEcCtD
Vigabatrin—Weight increased—Mitoxantrone—lymphatic system cancer	0.00273	0.00273	CcSEcCtD
Vigabatrin—Neuropathy peripheral—Vincristine—lymphatic system cancer	0.0027	0.0027	CcSEcCtD
Vigabatrin—Pneumonia—Mitoxantrone—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Vigabatrin—Feeling abnormal—Teniposide—lymphatic system cancer	0.00269	0.00269	CcSEcCtD
Vigabatrin—Drowsiness—Mitoxantrone—lymphatic system cancer	0.00268	0.00268	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Teniposide—lymphatic system cancer	0.00267	0.00267	CcSEcCtD
Vigabatrin—Nausea—Mechlorethamine—lymphatic system cancer	0.00263	0.00263	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Fludarabine—lymphatic system cancer	0.00262	0.00262	CcSEcCtD
Vigabatrin—Conjunctivitis—Mitoxantrone—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Vigabatrin—Urinary tract infection—Mitoxantrone—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Vigabatrin—Urticaria—Teniposide—lymphatic system cancer	0.0026	0.0026	CcSEcCtD
Vigabatrin—Abdominal pain—Teniposide—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Vigabatrin—Body temperature increased—Teniposide—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Vigabatrin—Paraesthesia—Fludarabine—lymphatic system cancer	0.00258	0.00258	CcSEcCtD
Vigabatrin—Hallucination—Carmustine—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Vigabatrin—Hypoaesthesia—Carmustine—lymphatic system cancer	0.00257	0.00257	CcSEcCtD
Vigabatrin—Oedema peripheral—Carmustine—lymphatic system cancer	0.00255	0.00255	CcSEcCtD
Vigabatrin—Connective tissue disorder—Carmustine—lymphatic system cancer	0.00254	0.00254	CcSEcCtD
Vigabatrin—Dyspepsia—Fludarabine—lymphatic system cancer	0.00253	0.00253	CcSEcCtD
Vigabatrin—Dysarthria—Methotrexate—lymphatic system cancer	0.00252	0.00252	CcSEcCtD
Vigabatrin—Sinusitis—Mitoxantrone—lymphatic system cancer	0.00251	0.00251	CcSEcCtD
Vigabatrin—Decreased appetite—Fludarabine—lymphatic system cancer	0.0025	0.0025	CcSEcCtD
Vigabatrin—Visual impairment—Carmustine—lymphatic system cancer	0.00249	0.00249	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Fludarabine—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Vigabatrin—Fatigue—Fludarabine—lymphatic system cancer	0.00248	0.00248	CcSEcCtD
Vigabatrin—Hallucination—Vincristine—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Vigabatrin—Hypoaesthesia—Vincristine—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Vigabatrin—Pain—Fludarabine—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Vigabatrin—Constipation—Fludarabine—lymphatic system cancer	0.00246	0.00246	CcSEcCtD
Vigabatrin—Respiratory failure—Methotrexate—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Vigabatrin—Connective tissue disorder—Vincristine—lymphatic system cancer	0.00243	0.00243	CcSEcCtD
Vigabatrin—Eye disorder—Carmustine—lymphatic system cancer	0.00242	0.00242	CcSEcCtD
Vigabatrin—Hypersensitivity—Teniposide—lymphatic system cancer	0.00241	0.00241	CcSEcCtD
Vigabatrin—Ill-defined disorder—Bleomycin—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Vigabatrin—Pulmonary embolism—Methotrexate—lymphatic system cancer	0.00239	0.00239	CcSEcCtD
Vigabatrin—Anaemia—Bleomycin—lymphatic system cancer	0.00238	0.00238	CcSEcCtD
Vigabatrin—Feeling abnormal—Fludarabine—lymphatic system cancer	0.00237	0.00237	CcSEcCtD
Vigabatrin—Asthenia—Teniposide—lymphatic system cancer	0.00234	0.00234	CcSEcCtD
Vigabatrin—Malaise—Bleomycin—lymphatic system cancer	0.00233	0.00233	CcSEcCtD
Vigabatrin—Pruritus—Teniposide—lymphatic system cancer	0.00231	0.00231	CcSEcCtD
Vigabatrin—Depressed level of consciousness—Methotrexate—lymphatic system cancer	0.0023	0.0023	CcSEcCtD
Vigabatrin—Body temperature increased—Fludarabine—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Vigabatrin—Mental disorder—Carmustine—lymphatic system cancer	0.00227	0.00227	CcSEcCtD
Vigabatrin—Malnutrition—Carmustine—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Vigabatrin—Cough—Bleomycin—lymphatic system cancer	0.00225	0.00225	CcSEcCtD
Vigabatrin—Diarrhoea—Teniposide—lymphatic system cancer	0.00224	0.00224	CcSEcCtD
Vigabatrin—Chest pain—Bleomycin—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Vigabatrin—Myalgia—Bleomycin—lymphatic system cancer	0.0022	0.0022	CcSEcCtD
Vigabatrin—Back pain—Carmustine—lymphatic system cancer	0.00218	0.00218	CcSEcCtD
Vigabatrin—Discomfort—Bleomycin—lymphatic system cancer	0.00217	0.00217	CcSEcCtD
Vigabatrin—Mental disorder—Vincristine—lymphatic system cancer	0.00216	0.00216	CcSEcCtD
Vigabatrin—Confusional state—Bleomycin—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Vigabatrin—Vision blurred—Carmustine—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Vigabatrin—Hypersensitivity—Fludarabine—lymphatic system cancer	0.00212	0.00212	CcSEcCtD
Vigabatrin—Tremor—Carmustine—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Vigabatrin—Oedema—Bleomycin—lymphatic system cancer	0.00211	0.00211	CcSEcCtD
Vigabatrin—Infection—Bleomycin—lymphatic system cancer	0.00209	0.00209	CcSEcCtD
Vigabatrin—Anaemia—Carmustine—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Vigabatrin—Back pain—Vincristine—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Vigabatrin—Vomiting—Teniposide—lymphatic system cancer	0.00208	0.00208	CcSEcCtD
Vigabatrin—Agitation—Carmustine—lymphatic system cancer	0.00207	0.00207	CcSEcCtD
Vigabatrin—Asthenia—Fludarabine—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Vigabatrin—Rash—Teniposide—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Vigabatrin—Dermatitis—Teniposide—lymphatic system cancer	0.00206	0.00206	CcSEcCtD
Vigabatrin—Headache—Teniposide—lymphatic system cancer	0.00205	0.00205	CcSEcCtD
Vigabatrin—Pruritus—Fludarabine—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Vigabatrin—Back pain—Mitoxantrone—lymphatic system cancer	0.00203	0.00203	CcSEcCtD
Vigabatrin—Anaemia—Vincristine—lymphatic system cancer	0.00199	0.00199	CcSEcCtD
Vigabatrin—Agitation—Vincristine—lymphatic system cancer	0.00198	0.00198	CcSEcCtD
Vigabatrin—Vision blurred—Mitoxantrone—lymphatic system cancer	0.00197	0.00197	CcSEcCtD
Vigabatrin—Diarrhoea—Fludarabine—lymphatic system cancer	0.00196	0.00196	CcSEcCtD
Vigabatrin—Convulsion—Carmustine—lymphatic system cancer	0.00195	0.00195	CcSEcCtD
Vigabatrin—Ill-defined disorder—Mitoxantrone—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Vigabatrin—Nausea—Teniposide—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Vigabatrin—Anaemia—Mitoxantrone—lymphatic system cancer	0.00194	0.00194	CcSEcCtD
Vigabatrin—Vertigo—Vincristine—lymphatic system cancer	0.00193	0.00193	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Bleomycin—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Vigabatrin—Chest pain—Carmustine—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Vigabatrin—Myalgia—Carmustine—lymphatic system cancer	0.00192	0.00192	CcSEcCtD
Vigabatrin—Anxiety—Carmustine—lymphatic system cancer	0.00191	0.00191	CcSEcCtD
Vigabatrin—Paraesthesia—Bleomycin—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Vigabatrin—Malaise—Mitoxantrone—lymphatic system cancer	0.00189	0.00189	CcSEcCtD
Vigabatrin—Convulsion—Vincristine—lymphatic system cancer	0.00186	0.00186	CcSEcCtD
Vigabatrin—Confusional state—Carmustine—lymphatic system cancer	0.00185	0.00185	CcSEcCtD
Vigabatrin—Oedema—Carmustine—lymphatic system cancer	0.00184	0.00184	CcSEcCtD
Vigabatrin—Decreased appetite—Bleomycin—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Vigabatrin—Myalgia—Vincristine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Vigabatrin—Cough—Mitoxantrone—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Vigabatrin—Infection—Carmustine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Vigabatrin—Vomiting—Fludarabine—lymphatic system cancer	0.00183	0.00183	CcSEcCtD
Vigabatrin—Convulsion—Mitoxantrone—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Vigabatrin—Rash—Fludarabine—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Vigabatrin—Dermatitis—Fludarabine—lymphatic system cancer	0.00181	0.00181	CcSEcCtD
Vigabatrin—Pain—Bleomycin—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Vigabatrin—Headache—Fludarabine—lymphatic system cancer	0.0018	0.0018	CcSEcCtD
Vigabatrin—Arthralgia—Mitoxantrone—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Vigabatrin—Chest pain—Mitoxantrone—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Vigabatrin—Myalgia—Mitoxantrone—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Vigabatrin—Anxiety—Mitoxantrone—lymphatic system cancer	0.00178	0.00178	CcSEcCtD
Vigabatrin—Lethargy—Methotrexate—lymphatic system cancer	0.00177	0.00177	CcSEcCtD
Vigabatrin—Discomfort—Mitoxantrone—lymphatic system cancer	0.00176	0.00176	CcSEcCtD
Vigabatrin—Oedema—Vincristine—lymphatic system cancer	0.00175	0.00175	CcSEcCtD
Vigabatrin—Infection—Vincristine—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Vigabatrin—Feeling abnormal—Bleomycin—lymphatic system cancer	0.00174	0.00174	CcSEcCtD
Vigabatrin—Osteoarthritis—Methotrexate—lymphatic system cancer	0.00173	0.00173	CcSEcCtD
Vigabatrin—Confusional state—Mitoxantrone—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Vigabatrin—Nervous system disorder—Vincristine—lymphatic system cancer	0.00172	0.00172	CcSEcCtD
Vigabatrin—Oedema—Mitoxantrone—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Vigabatrin—Nausea—Fludarabine—lymphatic system cancer	0.00171	0.00171	CcSEcCtD
Vigabatrin—Infection—Mitoxantrone—lymphatic system cancer	0.0017	0.0017	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Carmustine—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Vigabatrin—Urticaria—Bleomycin—lymphatic system cancer	0.00167	0.00167	CcSEcCtD
Vigabatrin—Body temperature increased—Bleomycin—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Vigabatrin—Insomnia—Carmustine—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Vigabatrin—Skin disorder—Mitoxantrone—lymphatic system cancer	0.00166	0.00166	CcSEcCtD
Vigabatrin—Irritability—Methotrexate—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Vigabatrin—Paraesthesia—Carmustine—lymphatic system cancer	0.00165	0.00165	CcSEcCtD
Vigabatrin—Mood swings—Methotrexate—lymphatic system cancer	0.00164	0.00164	CcSEcCtD
Vigabatrin—Somnolence—Carmustine—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Vigabatrin—Ataxia—Methotrexate—lymphatic system cancer	0.00163	0.00163	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Vincristine—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Vigabatrin—Decreased appetite—Carmustine—lymphatic system cancer	0.0016	0.0016	CcSEcCtD
Vigabatrin—Insomnia—Vincristine—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Carmustine—lymphatic system cancer	0.00159	0.00159	CcSEcCtD
Vigabatrin—Paraesthesia—Vincristine—lymphatic system cancer	0.00158	0.00158	CcSEcCtD
Vigabatrin—Pain—Carmustine—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Vigabatrin—Constipation—Carmustine—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Vigabatrin—Breast disorder—Methotrexate—lymphatic system cancer	0.00157	0.00157	CcSEcCtD
Vigabatrin—Toxic epidermal necrolysis—Methotrexate—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Mitoxantrone—lymphatic system cancer	0.00156	0.00156	CcSEcCtD
Vigabatrin—Hypersensitivity—Bleomycin—lymphatic system cancer	0.00155	0.00155	CcSEcCtD
Vigabatrin—Paraesthesia—Mitoxantrone—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Vigabatrin—Decreased appetite—Vincristine—lymphatic system cancer	0.00153	0.00153	CcSEcCtD
Vigabatrin—Somnolence—Mitoxantrone—lymphatic system cancer	0.00152	0.00152	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Vincristine—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Vigabatrin—Feeling abnormal—Carmustine—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Vigabatrin—Fatigue—Vincristine—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Vigabatrin—Asthenia—Bleomycin—lymphatic system cancer	0.00151	0.00151	CcSEcCtD
Vigabatrin—Dyspepsia—Mitoxantrone—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Carmustine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Vigabatrin—Pain—Vincristine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Vigabatrin—Constipation—Vincristine—lymphatic system cancer	0.0015	0.0015	CcSEcCtD
Vigabatrin—Pruritus—Bleomycin—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Vigabatrin—Decreased appetite—Mitoxantrone—lymphatic system cancer	0.00149	0.00149	CcSEcCtD
Vigabatrin—Fatigue—Mitoxantrone—lymphatic system cancer	0.00147	0.00147	CcSEcCtD
Vigabatrin—Constipation—Mitoxantrone—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Vigabatrin—Pain—Mitoxantrone—lymphatic system cancer	0.00146	0.00146	CcSEcCtD
Vigabatrin—Abdominal pain—Carmustine—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Vigabatrin—Body temperature increased—Carmustine—lymphatic system cancer	0.00145	0.00145	CcSEcCtD
Vigabatrin—Abdominal discomfort—Methotrexate—lymphatic system cancer	0.00144	0.00144	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Vincristine—lymphatic system cancer	0.00143	0.00143	CcSEcCtD
Vigabatrin—Feeling abnormal—Mitoxantrone—lymphatic system cancer	0.00141	0.00141	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Mitoxantrone—lymphatic system cancer	0.0014	0.0014	CcSEcCtD
Vigabatrin—Upper respiratory tract infection—Methotrexate—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Vigabatrin—Abdominal pain—Vincristine—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Vigabatrin—Body temperature increased—Vincristine—lymphatic system cancer	0.00139	0.00139	CcSEcCtD
Vigabatrin—Erectile dysfunction—Methotrexate—lymphatic system cancer	0.00138	0.00138	CcSEcCtD
Vigabatrin—Urticaria—Mitoxantrone—lymphatic system cancer	0.00136	0.00136	CcSEcCtD
Vigabatrin—Hypersensitivity—Carmustine—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Vigabatrin—Abdominal pain—Mitoxantrone—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Vigabatrin—Body temperature increased—Mitoxantrone—lymphatic system cancer	0.00135	0.00135	CcSEcCtD
Vigabatrin—Pneumonia—Methotrexate—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Vigabatrin—Vomiting—Bleomycin—lymphatic system cancer	0.00134	0.00134	CcSEcCtD
Vigabatrin—Drowsiness—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Vigabatrin—Infestation—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Vigabatrin—Infestation NOS—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Vigabatrin—Depression—Methotrexate—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Vigabatrin—Rash—Bleomycin—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Vigabatrin—Dermatitis—Bleomycin—lymphatic system cancer	0.00133	0.00133	CcSEcCtD
Vigabatrin—Stevens-Johnson syndrome—Methotrexate—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Vigabatrin—Asthenia—Carmustine—lymphatic system cancer	0.00132	0.00132	CcSEcCtD
Vigabatrin—Conjunctivitis—Methotrexate—lymphatic system cancer	0.0013	0.0013	CcSEcCtD
Vigabatrin—Hypersensitivity—Vincristine—lymphatic system cancer	0.00129	0.00129	CcSEcCtD
Vigabatrin—Hepatobiliary disease—Methotrexate—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Vigabatrin—Hypersensitivity—Mitoxantrone—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Vigabatrin—Asthenia—Vincristine—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Vigabatrin—Diarrhoea—Carmustine—lymphatic system cancer	0.00126	0.00126	CcSEcCtD
Vigabatrin—Nausea—Bleomycin—lymphatic system cancer	0.00125	0.00125	CcSEcCtD
Vigabatrin—Asthenia—Mitoxantrone—lymphatic system cancer	0.00123	0.00123	CcSEcCtD
Vigabatrin—Dizziness—Carmustine—lymphatic system cancer	0.00122	0.00122	CcSEcCtD
Vigabatrin—Diarrhoea—Vincristine—lymphatic system cancer	0.0012	0.0012	CcSEcCtD
Vigabatrin—Diarrhoea—Mitoxantrone—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Vigabatrin—Vomiting—Carmustine—lymphatic system cancer	0.00117	0.00117	CcSEcCtD
Vigabatrin—Dizziness—Vincristine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Vigabatrin—Rash—Carmustine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Vigabatrin—Dermatitis—Carmustine—lymphatic system cancer	0.00116	0.00116	CcSEcCtD
Vigabatrin—Visual impairment—Methotrexate—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Vigabatrin—Headache—Carmustine—lymphatic system cancer	0.00115	0.00115	CcSEcCtD
Vigabatrin—Erythema multiforme—Methotrexate—lymphatic system cancer	0.00113	0.00113	CcSEcCtD
Vigabatrin—Eye disorder—Methotrexate—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Vigabatrin—Tinnitus—Methotrexate—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Vigabatrin—Vomiting—Vincristine—lymphatic system cancer	0.00112	0.00112	CcSEcCtD
Vigabatrin—Rash—Vincristine—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Vigabatrin—Dermatitis—Vincristine—lymphatic system cancer	0.00111	0.00111	CcSEcCtD
Vigabatrin—Headache—Vincristine—lymphatic system cancer	0.0011	0.0011	CcSEcCtD
Vigabatrin—Nausea—Carmustine—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Vigabatrin—Vomiting—Mitoxantrone—lymphatic system cancer	0.00109	0.00109	CcSEcCtD
Vigabatrin—Rash—Mitoxantrone—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Vigabatrin—Dermatitis—Mitoxantrone—lymphatic system cancer	0.00108	0.00108	CcSEcCtD
Vigabatrin—Headache—Mitoxantrone—lymphatic system cancer	0.00107	0.00107	CcSEcCtD
Vigabatrin—Mental disorder—Methotrexate—lymphatic system cancer	0.00105	0.00105	CcSEcCtD
Vigabatrin—Malnutrition—Methotrexate—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Vigabatrin—Nausea—Vincristine—lymphatic system cancer	0.00104	0.00104	CcSEcCtD
Vigabatrin—Nausea—Mitoxantrone—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Vigabatrin—Back pain—Methotrexate—lymphatic system cancer	0.00101	0.00101	CcSEcCtD
Vigabatrin—Vision blurred—Methotrexate—lymphatic system cancer	0.000983	0.000983	CcSEcCtD
Vigabatrin—Ill-defined disorder—Methotrexate—lymphatic system cancer	0.000968	0.000968	CcSEcCtD
Vigabatrin—Anaemia—Methotrexate—lymphatic system cancer	0.000964	0.000964	CcSEcCtD
Vigabatrin—Malaise—Methotrexate—lymphatic system cancer	0.000941	0.000941	CcSEcCtD
Vigabatrin—Vertigo—Methotrexate—lymphatic system cancer	0.000937	0.000937	CcSEcCtD
Vigabatrin—Cough—Methotrexate—lymphatic system cancer	0.00091	0.00091	CcSEcCtD
Vigabatrin—Convulsion—Methotrexate—lymphatic system cancer	0.000904	0.000904	CcSEcCtD
Vigabatrin—Arthralgia—Methotrexate—lymphatic system cancer	0.000888	0.000888	CcSEcCtD
Vigabatrin—Chest pain—Methotrexate—lymphatic system cancer	0.000888	0.000888	CcSEcCtD
Vigabatrin—Myalgia—Methotrexate—lymphatic system cancer	0.000888	0.000888	CcSEcCtD
Vigabatrin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lymphatic system cancer	0.000882	0.000882	CcSEcCtD
Vigabatrin—Discomfort—Methotrexate—lymphatic system cancer	0.000877	0.000877	CcSEcCtD
Vigabatrin—Confusional state—Methotrexate—lymphatic system cancer	0.000858	0.000858	CcSEcCtD
Vigabatrin—Infection—Methotrexate—lymphatic system cancer	0.000846	0.000846	CcSEcCtD
Vigabatrin—Nervous system disorder—Methotrexate—lymphatic system cancer	0.000835	0.000835	CcSEcCtD
Vigabatrin—Skin disorder—Methotrexate—lymphatic system cancer	0.000827	0.000827	CcSEcCtD
Vigabatrin—Musculoskeletal discomfort—Methotrexate—lymphatic system cancer	0.000776	0.000776	CcSEcCtD
Vigabatrin—Insomnia—Methotrexate—lymphatic system cancer	0.00077	0.00077	CcSEcCtD
Vigabatrin—Paraesthesia—Methotrexate—lymphatic system cancer	0.000764	0.000764	CcSEcCtD
Vigabatrin—Somnolence—Methotrexate—lymphatic system cancer	0.000757	0.000757	CcSEcCtD
Vigabatrin—Dyspepsia—Methotrexate—lymphatic system cancer	0.000749	0.000749	CcSEcCtD
Vigabatrin—Decreased appetite—Methotrexate—lymphatic system cancer	0.00074	0.00074	CcSEcCtD
Vigabatrin—Gastrointestinal disorder—Methotrexate—lymphatic system cancer	0.000735	0.000735	CcSEcCtD
Vigabatrin—Fatigue—Methotrexate—lymphatic system cancer	0.000734	0.000734	CcSEcCtD
Vigabatrin—Pain—Methotrexate—lymphatic system cancer	0.000728	0.000728	CcSEcCtD
Vigabatrin—Feeling abnormal—Methotrexate—lymphatic system cancer	0.000702	0.000702	CcSEcCtD
Vigabatrin—Gastrointestinal pain—Methotrexate—lymphatic system cancer	0.000696	0.000696	CcSEcCtD
Vigabatrin—Urticaria—Methotrexate—lymphatic system cancer	0.000676	0.000676	CcSEcCtD
Vigabatrin—Abdominal pain—Methotrexate—lymphatic system cancer	0.000673	0.000673	CcSEcCtD
Vigabatrin—Body temperature increased—Methotrexate—lymphatic system cancer	0.000673	0.000673	CcSEcCtD
Vigabatrin—Hypersensitivity—Methotrexate—lymphatic system cancer	0.000627	0.000627	CcSEcCtD
Vigabatrin—Asthenia—Methotrexate—lymphatic system cancer	0.000611	0.000611	CcSEcCtD
Vigabatrin—Pruritus—Methotrexate—lymphatic system cancer	0.000602	0.000602	CcSEcCtD
Vigabatrin—Diarrhoea—Methotrexate—lymphatic system cancer	0.000583	0.000583	CcSEcCtD
Vigabatrin—Dizziness—Methotrexate—lymphatic system cancer	0.000563	0.000563	CcSEcCtD
Vigabatrin—Vomiting—Methotrexate—lymphatic system cancer	0.000541	0.000541	CcSEcCtD
Vigabatrin—Rash—Methotrexate—lymphatic system cancer	0.000537	0.000537	CcSEcCtD
Vigabatrin—Dermatitis—Methotrexate—lymphatic system cancer	0.000536	0.000536	CcSEcCtD
Vigabatrin—Headache—Methotrexate—lymphatic system cancer	0.000533	0.000533	CcSEcCtD
Vigabatrin—Nausea—Methotrexate—lymphatic system cancer	0.000506	0.000506	CcSEcCtD
